FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT By and Among Quanterix Corporation; the Founders as defined herein; the Investors as defined herein and STRATEC as defined herein Dated as of June 2, 2017Stockholders Agreement • November 9th, 2017 • Quanterix Corp • Laboratory analytical instruments • Delaware
Contract Type FiledNovember 9th, 2017 Company Industry JurisdictionThis FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (the “Agreement”) is made as of June 2, 2017, by and among Quanterix Corporation, a Delaware corporation (the “Company”), the individuals identified on Schedule A hereto as Founders (collectively, the “Founders,” and each individually, a “Founder”), the Persons identified on Schedule A hereto as the Investors (each, an “Investor” and collectively, the “Investors”), STRATEC Biomedical Systems AG (“STRATEC”), and any other stockholder or option holder who from time to time becomes party to this Agreement by execution of a Joinder Agreement in substantially the form attached hereto as Exhibit A. The Founders, the Investors, STRATEC, and anyone who becomes a party to this Agreement pursuant to Section 7.16 below are sometimes referred to herein collectively as the “Stockholders,” and each individually, a “Stockholder.”
FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT By and Among Quanterix Corporation; the Founders as defined herein; the Investors as defined herein and STRATEC as defined herein Dated as of June 2, 2017Stockholders Agreement • July 21st, 2017 • Quanterix Corp • Laboratory analytical instruments • Delaware
Contract Type FiledJuly 21st, 2017 Company Industry JurisdictionThis FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (the “Agreement”) is made as of June 2, 2017, by and among Quanterix Corporation, a Delaware corporation (the “Company”), the individuals identified on Schedule A hereto as Founders (collectively, the “Founders,” and each individually, a “Founder”), the Persons identified on Schedule A hereto as the Investors (each, an “Investor” and collectively, the “Investors”), STRATEC Biomedical Systems AG (“STRATEC”), and any other stockholder or option holder who from time to time becomes party to this Agreement by execution of a Joinder Agreement in substantially the form attached hereto as Exhibit A. The Founders, the Investors, STRATEC, and anyone who becomes a party to this Agreement pursuant to Section 7.16 below are sometimes referred to herein collectively as the “Stockholders,” and each individually, a “Stockholder.”